Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

Charite University, Berlin, Germany · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
ras
colorectal cancer metastatic, metastatic colorectal cancer, ras, braf, cetuximab, ctdna, treatment break, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 854564
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.